Ranbaxy under fire: now faces hospital advisory
This article was originally published in Scrip
Executive Summary
Ranbaxy remains under attack in India, with new reports that a prominent Mumbai-based hospital has issued an advisory against its products after the company pleaded guilty and agreed to settle felony charges in the US of manufacturing and distributing adulterated drugs made at two Indian sites.